Compare EU & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EU | TMCI |
|---|---|---|
| Founded | 2009 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 306.9M | 279.6M |
| IPO Year | 2011 | 2021 |
| Metric | EU | TMCI |
|---|---|---|
| Price | $1.24 | $4.68 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 6 |
| Target Price | $4.00 | ★ $4.77 |
| AVG Volume (30 Days) | ★ 2.9M | 393.4K |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.76 | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | $43,155,000.00 | ★ $212,690,000.00 |
| Revenue This Year | $212.11 | N/A |
| Revenue Next Year | $29.88 | $8.18 |
| P/E Ratio | $41.00 | ★ N/A |
| Revenue Growth | N/A | ★ 1.59 |
| 52 Week Low | $1.03 | $1.17 |
| 52 Week High | $4.19 | $7.78 |
| Indicator | EU | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 42.29 | 52.55 |
| Support Level | N/A | $3.84 |
| Resistance Level | $1.79 | $4.67 |
| Average True Range (ATR) | 0.07 | 0.28 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 47.83 | 52.48 |
enCore Energy Corp together with its subsidiary, is principally engaged in the acquisition, exploration, development and extraction of uranium resource properties in the United States. The Company is focused on the extraction of domestic uranium in the United States. The Company utilizes the In-Situ Recovery technology (ISR) to provide necessary fuel for the generation of clean, reliable, and carbon-free nuclear energy.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.